BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pan XY, You HM, Wang L, Bi YH, Yang Y, Meng HW, Meng XM, Ma TT, Huang C, Li J. Methylation of RCAN1.4 mediated by DNMT1 and DNMT3b enhances hepatic stellate cell activation and liver fibrogenesis through Calcineurin/NFAT3 signaling. Theranostics 2019;9:4308-23. [PMID: 31285763 DOI: 10.7150/thno.32710] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Bu FT, Jia PC, Zhu Y, Yang YR, Meng HW, Bi YH, Huang C, Li J. Emerging therapeutic potential of adeno-associated virus-mediated gene therapy in liver fibrosis. Mol Ther Methods Clin Dev 2022;26:191-206. [PMID: 35859692 DOI: 10.1016/j.omtm.2022.06.009] [Reference Citation Analysis]
2 Yang X, Yun Y, Wang P, Zhao J, Sun X. Upregulation of RCAN1.4 by HIF1α alleviates OGD-induced inflammatory response in astrocytes. Ann Clin Transl Neurol 2022. [PMID: 35836352 DOI: 10.1002/acn3.51624] [Reference Citation Analysis]
3 Lao M, Zhang X, Yang H, Bai X, Liang T. RCAN1-mediated calcineurin inhibition as a target for cancer therapy. Mol Med 2022;28:69. [PMID: 35717152 DOI: 10.1186/s10020-022-00492-7] [Reference Citation Analysis]
4 Zhong QH, Zha SW, Lau ATY, Xu YM. Recent knowledge of NFATc4 in oncogenesis and cancer prognosis. Cancer Cell Int 2022;22:212. [PMID: 35698138 DOI: 10.1186/s12935-022-02619-6] [Reference Citation Analysis]
5 Xu JJ, Zhu L, Li HD, Du XS, Li JJ, Yin NN, Meng XM, Huang C, Li J. DNMT3a-mediated methylation of PSTPIP2 enhances inflammation in alcohol-induced liver injury via regulating STAT1 and NF-κB pathway. Pharmacol Res 2022;:106125. [PMID: 35149186 DOI: 10.1016/j.phrs.2022.106125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bai X, Gao M, Li Y, Chen H, Ma X, Bai H, Liu Y, Hu X, Suo Z. Upregulation of RCAN1.4 in spinal dorsal horn is involved in inflammatory pain hypersensitivity. Neuroscience Letters 2022. [DOI: 10.1016/j.neulet.2022.136538] [Reference Citation Analysis]
7 Zhang J, Liu Q, He J, Li Y. Novel Therapeutic Targets in Liver Fibrosis. Front Mol Biosci 2021;8:766855. [PMID: 34805276 DOI: 10.3389/fmolb.2021.766855] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Zhang J, Chen H, Weng X, Liu H, Chen Z, Huang Q, Wang L, Liu X. RCAN1.4 attenuates renal fibrosis through inhibiting calcineurin-mediated nuclear translocation of NFAT2. Cell Death Discov 2021;7:317. [PMID: 34707090 DOI: 10.1038/s41420-021-00713-8] [Reference Citation Analysis]
9 Wang L, You HM, Meng HW, Pan XY, Chen X, Bi YH, Zhang YF, Li JJ, Yin NN, Zhang ZW, Huang C, Li J. STING-mediated inflammation contributes to Gao binge ethanol feeding model. J Cell Physiol 2021. [PMID: 34698390 DOI: 10.1002/jcp.30606] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Cao Y, Zhan Y, Qiu S, Chen Z, Gong K, Ni S, Duan Y. Integrative analysis of genome-wide DNA methylation and single-nucleotide polymorphism identified ACSM5 as a suppressor of lumbar ligamentum flavum hypertrophy. Arthritis Res Ther 2021;23:251. [PMID: 34593020 DOI: 10.1186/s13075-021-02625-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Xue T, Qiu X, Liu H, Gan C, Tan Z, Xie Y, Wang Y, Ye T. Epigenetic regulation in fibrosis progress. Pharmacol Res 2021;173:105910. [PMID: 34562602 DOI: 10.1016/j.phrs.2021.105910] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 Peng XF, Huang SF, Chen LJ, Xu L, Ye WC. Targeting epigenetics and lncRNAs in liver disease: From mechanisms to therapeutics. Pharmacol Res 2021;172:105846. [PMID: 34438063 DOI: 10.1016/j.phrs.2021.105846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wei H, Chen Z, Zheng Y, Chen Q, Min H, Ma Q, Gao B, Mo S. Calreticulin silencing inhibits extracellular matrix synthesis of human gingival fibroblasts cultured on three-dimensional poly(lactic-co-glycolic acid) scaffolds by inhibiting the calcineurin/nuclear factor of activated T cells 3 signalling pathway. Ann Anat 2021;239:151820. [PMID: 34411706 DOI: 10.1016/j.aanat.2021.151820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 You H, Wang L, Bu F, Meng H, Pan X, Li J, Zhang Y, Wang A, Yin N, Huang C, Li J. The miR-455-3p/HDAC2 axis plays a pivotal role in the progression and reversal of liver fibrosis and is regulated by epigenetics. FASEB J 2021;35:e21700. [PMID: 34105828 DOI: 10.1096/fj.202002319RRR] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Huang B, Jiang Z, Wu S, Wu H, Zhang X, Chen J, Zhao F, Liu J. RCAN1.4 suppresses the osteosarcoma growth and metastasis via interfering with the calcineurin/NFAT signaling pathway. J Bone Oncol 2021;30:100383. [PMID: 34336566 DOI: 10.1016/j.jbo.2021.100383] [Reference Citation Analysis]
16 Wang F, Malnassy G, Qiu W. The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma. Front Oncol 2021;11:653037. [PMID: 33791228 DOI: 10.3389/fonc.2021.653037] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Shi Z, Zhang K, Chen T, Zhang Y, Du X, Zhao Y, Shao S, Zheng L, Han T, Hong W. Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells. Cell Death Dis 2020;11:1066. [PMID: 33311456 DOI: 10.1038/s41419-020-03271-6] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Zhu Y, Pan X, Du N, Li K, Hu Y, Wang L, Zhang J, Liu Y, Zuo L, Meng X, Hu C, Wu X, Jin J, Wu W, Chen X, Wu F, Huang Y. ASIC1a regulates miR‐350/SPRY2 by N 6 ‐methyladenosine to promote liver fibrosis. FASEB j 2020;34:14371-88. [DOI: 10.1096/fj.202001337r] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
19 Zhu H, He C, Zhao H, Jiang W, Xu S, Li J, Ma T, Huang C. Sennoside A prevents liver fibrosis by binding DNMT1 and suppressing DNMT1-mediated PTEN hypermethylation in HSC activation and proliferation. FASEB J 2020;34:14558-71. [PMID: 32946656 DOI: 10.1096/fj.202000494RR] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
20 Yang M, Liu Q, Huang T, Tan W, Qu L, Chen T, Pan H, Chen L, Liu J, Wong CW, Lu WW, Guan M. Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development. Theranostics 2020;10:10874-91. [PMID: 33042259 DOI: 10.7150/thno.47037] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
21 Yang YR, Bu FT, Yang Y, Li H, Huang C, Meng XM, Zhang L, Lv XW, Li J. LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-β1/Smad3 pathway. Mol Immunol 2020;126:31-9. [PMID: 32745796 DOI: 10.1016/j.molimm.2020.07.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
22 Li H, Chen X, Xu J, Du X, Yang Y, Li J, Yang X, Huang H, Li X, Wu M, Zhang C, Zhang C, Li Z, Wang H, Meng X, Huang C, Li J. DNMT3b-mediated methylation of ZSWIM3 enhances inflammation in alcohol-induced liver injury via regulating TRAF2-mediated NF-κB pathway. Clinical Science 2020;134:1935-56. [DOI: 10.1042/cs20200031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Li H, Chen X, Xu J, Du X, Yang Y, Li J, Yang X, Huang H, Li X, Wu M, Zhang C, Zhang C, Li Z, Wang H, Meng X, Huang C, Li J. DNMT3b-mediated methylation of ZSWIM3 enhances inflammation in alcohol-induced liver injury via regulating TRAF2-mediated NF-κB pathway. Clinical Science 2020;134:1935-56. [DOI: 10.1042/cs20200031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
24 Fan J, Shen W, Lee SR, Mathai AE, Zhang R, Xu G, Gillies MC. Targeting the Notch and TGF-β signaling pathways to prevent retinal fibrosis in vitro and in vivo. Theranostics 2020;10:7956-73. [PMID: 32724452 DOI: 10.7150/thno.45192] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
25 Jagadeesh A, Maroun LE, Van Es LM, Millis RM. Autoimmune Mechanisms of Interferon Hypersensitivity and Neurodegenerative Diseases: Down Syndrome. Autoimmune Dis 2020;2020:6876920. [PMID: 32566271 DOI: 10.1155/2020/6876920] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Teng H, Xue M, Liang J, Wang X, Wang L, Wei W, Li C, Zhang Z, Li Q, Ran X, Shi X, Cai W, Wang W, Gao H, Sun Z. Inter- and intratumor DNA methylation heterogeneity associated with lymph node metastasis and prognosis of esophageal squamous cell carcinoma. Theranostics 2020;10:3035-48. [PMID: 32194853 DOI: 10.7150/thno.42559] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
27 Wang M, Zhang M, Fu L, Lin J, Zhou X, Zhou P, Huang P, Hu H, Han Y. Liver-targeted delivery of TSG-6 by calcium phosphate nanoparticles for the management of liver fibrosis. Theranostics 2020;10:36-49. [PMID: 31903104 DOI: 10.7150/thno.37301] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
28 Zhao L, Liu Y, Zhang J, Liu Y, Qi Q. LncRNA SNHG14/miR-5590-3p/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD-1/PD-L1 checkpoint. Cell Death Dis 2019;10:731. [PMID: 31570691 DOI: 10.1038/s41419-019-1886-5] [Cited by in Crossref: 46] [Cited by in F6Publishing: 86] [Article Influence: 15.3] [Reference Citation Analysis]